New pill tested to fight deadly lung scarring
NCT ID NCT06325696
Summary
This study is testing an oral drug called H01 (hymecromone) in adults with progressive interstitial lung disease, a condition that causes scarring and thickening of lung tissue. The main goal is to see if H01 can reduce levels of a substance called hyaluronan in the blood, which is linked to the disease process. Researchers will also check the drug's safety and see if it helps improve lung function, walking ability, and quality of life over a 12-week treatment period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NIEHS Clinical Research Unit (CRU)
RECRUITINGResearch Triangle Park, North Carolina, 27709, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.